Selegiline Patch Suppliers & Bulk Manufacturers
Available Forms: Patches
Available Strengths: 6 mg/24 hr, 9 mg/24 hr, and 12 mg/24 hr patches
Reference Brands: Emsam
Category:
Transdermal Patches
Selegiline patches deliver selegiline steadily through the skin, inhibiting monoamine oxidase B (MAO-B), which increases dopamine levels in the brain. Benefits include improved motor function in Parkinson’s disease, enhanced mood, reduced medication fluctuations, and better patient compliance, supporting long-term disease management and quality of life.
Selegiline Patch is available in Patches
and strengths such as 6 mg/24 hr, 9 mg/24 hr, and 12 mg/24 hr patches.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Selegiline Patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Selegiline Patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Selegiline patches are regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, FDA approval involves validation, safety assessments, and GMP compliance, while in the EU, CE marking certifies conformity with MDR standards. These products undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to safe, effective selegiline transdermal patches, supporting Parkinson’s disease management and improving patient adherence globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing